{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T07:14:04Z","timestamp":1788678844738,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10147-026-03004-3","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:26:24Z","timestamp":1772457984000},"page":"859-867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term follow-up of neoadjuvant chemotherapy in resectable human papillomavirus-associated oropharyngeal cancer"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-1834","authenticated-orcid":false,"given":"Ryo","family":"Kawaura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7327-7949","authenticated-orcid":false,"given":"Tomoya","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Fushiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1019-7564","authenticated-orcid":false,"given":"Yusuke","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mukaigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Onitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"3004_CR1","unstructured":"Society AC (2025) Key statistics for oral cavity and oropharyngeal cancers. https:\/\/www.cancer.org\/cancer\/types\/oral-cavity-and-oropharyngeal-cancer\/about\/key-statistics.html. Accessed 19 Oct 2025"},{"key":"3004_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/jso.23292","volume":"107","author":"J Klozar","year":"2013","unstructured":"Klozar J, Koslabova E, Kratochvil V et al (2013) Nodal status is not a prognostic factor in patients with HPV-positive oral\/oropharyngeal tumors. J Surg Oncol 107:625\u2013633","journal-title":"J Surg Oncol"},{"key":"3004_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335","journal-title":"N Engl J Med"},{"key":"3004_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000360991","volume":"87","author":"T Hama","year":"2014","unstructured":"Hama T, Tokumaru Y, Fujii M et al (2014) Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology 87:173\u2013182","journal-title":"Oncology"},{"key":"3004_CR5","unstructured":"NRG-Oncology (2024) A randomized phase II\/III trial of de-intensified radiation therapy for patients with early-stage, p16-positive, Non-Smoking Associated Oropharyngeal Cancer (NRG-HN005). https:\/\/www.nrgoncology.org\/Clinical-Trials\/Protocol\/nrg-hn005?filter=nrg-hn005. Accessed 12 Nov 2025"},{"key":"3004_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","volume":"393","author":"ML Gillison","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J et al (2019) Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 393:40\u201350","journal-title":"Lancet"},{"key":"3004_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","volume":"18","author":"AM Chen","year":"2017","unstructured":"Chen AM, Felix C, Wang PC et al (2017) Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. Lancet Oncol 18:803\u2013811","journal-title":"Lancet Oncol"},{"key":"3004_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","volume":"35","author":"S Marur","year":"2017","unstructured":"Marur S, Li S, Cmelak AJ et al (2017) E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN Cancer Research Group. J Clin Oncol 35:490\u2013497","journal-title":"J Clin Oncol"},{"key":"3004_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdy522","volume":"30","author":"TY Seiwert","year":"2019","unstructured":"Seiwert TY, Foster CC, Blair EA et al (2019) OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann Oncol 30:297\u2013302","journal-title":"Ann Oncol"},{"key":"3004_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","volume":"20","author":"AC Nichols","year":"2019","unstructured":"Nichols AC, Theurer J, Prisman E et al (2019) Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol 20:1349\u20131359","journal-title":"Lancet Oncol"},{"key":"3004_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104608","volume":"103","author":"RR Patel","year":"2020","unstructured":"Patel RR, Ludmir EB, Augustyn A et al (2020) De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: a systematic review of prospective trials. Oral Oncol 103:104608","journal-title":"Oral Oncol"},{"key":"3004_CR12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10147-021-01894-z","volume":"26","author":"T Yokota","year":"2021","unstructured":"Yokota T, Onitsuka T, Hamauchi S et al (2021) Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: why is it successful or unsuccessful? Int J Clin Oncol 26:1039\u20131048","journal-title":"Int J Clin Oncol"},{"key":"3004_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.10.014","volume":"75","author":"YM Park","year":"2017","unstructured":"Park YM, Kim HR, Cho BC et al (2017) Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma. Oral Oncol 75:16\u201321","journal-title":"Oral Oncol"},{"key":"3004_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hed.26022","volume":"42","author":"N Sadeghi","year":"2020","unstructured":"Sadeghi N, Khalife S, Mascarella MA et al (2020) Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer. Head Neck 42:417\u2013425","journal-title":"Head Neck"},{"key":"3004_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/lary.28180","volume":"130","author":"MS Burke","year":"2020","unstructured":"Burke MS, Loree JT, Popat SR et al (2020) Presurgical induction chemotherapy for squamous cell carcinoma of the tonsil. Laryngoscope 130:1206\u20131211","journal-title":"Laryngoscope"},{"key":"3004_CR16","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/annonc\/mdx202","volume":"28","author":"J Inhestern","year":"2017","unstructured":"Inhestern J, Schmalenberg H, Dietz A et al (2017) A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). Ann Oncol 28:1917\u20131922","journal-title":"Ann Oncol"},{"key":"3004_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1200\/JCO.2003.06.146","volume":"21","author":"L Licitra","year":"2003","unstructured":"Licitra L, Grandi C, Guzzo M et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327\u2013333","journal-title":"J Clin Oncol"},{"key":"3004_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","volume":"31","author":"LP Zhong","year":"2013","unstructured":"Zhong LP, Zhang CP, Ren GX et al (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31:744\u2013751","journal-title":"J Clin Oncol"},{"key":"3004_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/annonc\/mdt555","volume":"25","author":"P Bossi","year":"2014","unstructured":"Bossi P, Lo Vullo S, Guzzo M et al (2014) Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial. Ann Oncol 25:462\u2013466","journal-title":"Ann Oncol"},{"key":"3004_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.21.00179","volume":"40","author":"D Chaukar","year":"2022","unstructured":"Chaukar D, Prabash K, Rane P et al (2022) Prospective phase II open-label randomized controlled trial to compare mandibular preservation in upfront surgery with neoadjuvant chemotherapy followed by surgery in operable oral cavity cancer. J Clin Oncol 40:272\u2013281","journal-title":"J Clin Oncol"},{"key":"3004_CR21","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.ejca.2015.08.007","volume":"51","author":"GN Marta","year":"2015","unstructured":"Marta GN, Riera R, Bossi P et al (2015) Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: systematic review and meta-analysis. Eur J Cancer 51:2596\u20132603","journal-title":"Eur J Cancer"},{"key":"3004_CR22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/jjco\/hyx097","volume":"47","author":"H Hirakawa","year":"2017","unstructured":"Hirakawa H, Hanai N, Suzuki H et al (2017) Prognostic importance of pathological response to neoadjuvant chemotherapy followed by definitive surgery in advanced oral squamous cell carcinoma. Jpn J Clin Oncol 47:1038\u20131046","journal-title":"Jpn J Clin Oncol"},{"key":"3004_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.107139","volume":"161","author":"AR Pershad","year":"2025","unstructured":"Pershad AR, Ferraro T, Shaver TB et al (2025) Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer. Oral Oncol 161:107139","journal-title":"Oral Oncol"},{"key":"3004_CR24","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1002\/cncr.33062","volume":"126","author":"Y Saito","year":"2020","unstructured":"Saito Y, Hayashi R, Iida Y et al (2020) Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: multi-institutional observational study based on the national head and neck cancer registry of Japan. Cancer 126:4177\u20134187","journal-title":"Cancer"},{"key":"3004_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/1078-0432.CCR-23-1013","volume":"30","author":"H Mehanna","year":"2024","unstructured":"Mehanna H, Rapozo D, von Zeidler SV et al (2024) Developing and validating a multivariable prognostic-predictive classifier for treatment escalation of oropharyngeal squamous cell carcinoma: the PREDICTR-OPC study. Clin Cancer Res 30:356\u2013367","journal-title":"Clin Cancer Res"},{"key":"3004_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","volume":"88","author":"JL Lefebvre","year":"1996","unstructured":"Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 88:890\u2013899","journal-title":"J Natl Cancer Inst"},{"key":"3004_CR27","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091\u20132098","journal-title":"N Engl J Med"},{"key":"3004_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, le Maitre A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4\u201314","journal-title":"Radiother Oncol"},{"key":"3004_CR29","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","volume":"26","author":"M Machtay","year":"2008","unstructured":"Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582\u20133589","journal-title":"J Clin Oncol"},{"key":"3004_CR30","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ijrobp.2008.04.006","volume":"71","author":"AS Garden","year":"2008","unstructured":"Garden AS, Harris J, Trotti A et al (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99\u201314). Int J Radiat Oncol Biol Phys 71:1351\u20131355","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3004_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","volume":"31","author":"AA Forastiere","year":"2013","unstructured":"Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91\u201311: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845\u2013852","journal-title":"J Clin Oncol"},{"key":"3004_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.anl.2024.04.001","volume":"51","author":"K Tsukada","year":"2024","unstructured":"Tsukada K, Seino Y, Yamashita T (2024) The quality of life outcome in patients with head and neck squamous cell cancer treated using chemoradiotherapy. Auris Nasus Larynx 51:674\u2013679","journal-title":"Auris Nasus Larynx"},{"key":"3004_CR33","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00405-023-08432-9","volume":"281","author":"G Fiacchini","year":"2024","unstructured":"Fiacchini G, Picariello M, Dallan I et al (2024) Overall survival, disease-free survival and quality of life in patients affected by HPV mediated p16+ oropharyngeal squamous cell carcinoma treated with upfront trans-oral robotic surgery vs radiotherapy or chemoradiotherapy. Eur Arch Otorhinolaryngol 281:1913\u20131921","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3004_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.radonc.2021.11.011","volume":"166","author":"LM Kutz","year":"2022","unstructured":"Kutz LM, Abel J, Schweizer D et al (2022) Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: results from the prospective randomized HEADNUT-trial. Radiother Oncol 166:145\u2013153","journal-title":"Radiother Oncol"},{"key":"3004_CR35","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/lary.30534","volume":"133","author":"M Berg","year":"2023","unstructured":"Berg M, Silander E, Bove M et al (2023) Fatigue in long-term head and neck cancer survivors from diagnosis until five years after treatment. Laryngoscope 133:2211\u20132221","journal-title":"Laryngoscope"},{"key":"3004_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/hed.70065","author":"JJ Frowen","year":"2025","unstructured":"Frowen JJ, Drosdowsky A, Fua TF et al (2025) Patient-reported dysphagia and swallowing-related quality of life up to 10 years after (chemo)radiotherapy for head and neck cancer: a cross-sectional study. Head Neck. https:\/\/doi.org\/10.1002\/hed.70065","journal-title":"Head Neck"},{"key":"3004_CR37","volume":"2012","author":"H Ishiki","year":"2012","unstructured":"Ishiki H, Onozawa Y, Kojima T et al (2012) Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long? ISRN Oncol 2012:274739","journal-title":"ISRN Oncol"},{"key":"3004_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.08.1994","volume":"36","author":"T Yokota","year":"2025","unstructured":"Yokota T, Tsuzuki T, Onitsuka T et al (2025) 1362P Phase II trial of neoadjuvant chemotherapy with docetaxel plus cisplatin and 5-fluorouracil aiming at avoiding postoperative radiotherapy for HPV-associated oropharyngeal cancers (HIPPOCRATES). Ann Oncol 36:S846","journal-title":"Ann Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03004-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:34:46Z","timestamp":1776843286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03004-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors received no financial or material support from any organization for the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}